Category: Life Sciences
Global Life Sciences
-
Specialty (except Psychiatric and Substance Abuse) Hospitals
... expected to reach US$81.7 Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Cancer Hospitals, one of the segments analyzed in the report, is expected to record a 2.7% CAGR ... Read More
-
Veterinary Equipment and Disposables
... 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Critical Care Consumables, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$1.2 Billion by ... Read More
-
Albumin
... 3.8% over the analysis period 2024-2030. Human Serum Albumin, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$902.4 Million by the end of the analysis period. ... Read More
-
Automated Immunoassay Analyzers
... at a CAGR of 4.5% over the analysis period 2024-2030. Immunofluorescence Technology, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.2 Billion by the end of ... Read More
-
Biopharmaceutical Fermentation Systems
... at a CAGR of 4.5% over the analysis period 2024-2030. Upstream Products, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$6.5 Billion by the end of ... Read More
-
Hematology Diagnostics
... CAGR of 5.8% over the analysis period 2024-2030. Hematology Diagnostic Consumables, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$7.8 Billion by the end of the ... Read More
-
Hip Reconstruction Devices
... at a CAGR of 4.5% over the analysis period 2024-2030. Primary Hip Replacement Hip Reconstruction Devices, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$10.1 Billion ... Read More
-
Hip Replacement Implants
... at a CAGR of 3.5% over the analysis period 2024-2030. Total Hip Replacement Implant, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$8.6 Billion by the ... Read More
-
Nitinol Medical Devices
... at a CAGR of 6.9% over the analysis period 2024-2030. Nitinol Stents, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$11.6 Billion by the end of ... Read More
-
Digital Radiography
... CAGR of 5.9% over the analysis period 2024-2030. Computed Radiography (CR), one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$17.0 Billion by the end of the ... Read More
-
Lung Cancer Therapeutics
... at a CAGR of 10.8% over the analysis period 2024-2030. Non-Small-Cell Lung Cancer (NSCLC) Therapeutics, one of the segments analyzed in the report, is expected to record a 11.9% CAGR and reach US$82.3 Billion by ... Read More
-
Triacetin
... 4.3% over the analysis period 2024-2030. Triacetin Plasticizer, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$193.2 Million by the end of the analysis period. Growth ... Read More
-
Wi-Fi Hotspot
... CAGR of 17.0% over the analysis period 2024-2030. Wi-Fi Hotspot Hardware, one of the segments analyzed in the report, is expected to record a 15.4% CAGR and reach US$8.5 Billion by the end of the ... Read More
-
Bovine-Based Collagen for Biomedical Applications
... Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Bone Graft Substitutes Application, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach ... Read More
-
Transdermal Drug Delivery
... at a CAGR of 16.6% over the analysis period 2024-2030. Passive Delivery System, one of the segments analyzed in the report, is expected to record a 15.1% CAGR and reach US$123.5 Billion by the end ... Read More
-
Vascular Guidewires
... CAGR of 5.5% over the analysis period 2024-2030. Coronary Guidewires, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$786.2 Million by the end of the analysis ... Read More
-
Veterinary Infusion Pumps
... at a CAGR of 5.5% over the analysis period 2024-2030. Syringe Infusion Pumps, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$49.6 Million by the end ... Read More
-
Gluten Free Products
... at a CAGR of 5.9% over the analysis period 2024-2030. Gluten Free Bakery Products, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$4.7 Billion by the ... Read More
-
Industrial Protective Footwear
... at a CAGR of 6.6% over the analysis period 2024-2030. Leather Footwear, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$3.8 Billion by the end of ... Read More
-
Medical Waste Management
... at a CAGR of 4.2% over the analysis period 2024-2030. Collection, Transportation & Storage Services, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$10.4 Billion by ... Read More
-
Carotenoids
... 3.8% over the analysis period 2024-2030. Beta-Carotene, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in ... Read More
-
Anti-Obesity Drugs
... CAGR of 8.7% over the analysis period 2024-2030. Prescription Drugs, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$4.9 Billion by the end of the analysis ... Read More
-
Cardiac Biomarkers
... CAGR of 7.3% over the analysis period 2024-2030. Troponins (T & I), one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$11.2 Billion by the end of ... Read More
-
Prescription Drugs
... CAGR of 5.7% over the analysis period 2024-2030. Generic Drugsone of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$498.0 Billion by the end of the analysis period. ... Read More
-
Ophthalmic Lasers
... CAGR of 5.0% over the analysis period 2024-2030. Femtosecond Lasers, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$757.4 Million by the end of the analysis ... Read More
Research Assistance
